Ambient scribe
Nabla
Nabla gives clinicians and healthcare organizations control over documentation, coding, and retention settings. Patient access, refusal, and correction depend on the deployment. Earlier consent and training assurances were not fully reverified in this pass.
Checklist assessment dated October 30, 2026. Independent confirmation is incomplete. Hugo has not personally verified this service.
Agency checklist · October 30, 2026
Constrains 0 of 12 yes
Document-based draft. Independent confirmation is incomplete. Hugo has not personally verified this service.
Assessed function: Ambient AI scribe for clinicians: records the patient-clinician conversation and drafts the clinical note
A no can mean missing documentation or institution-dependent control; it does not by itself establish harmful behavior. These categories are not clinical safety or product-quality ratings.
- Public documents do not establish actual product behavior.
- The independent review screened rules and selected evidence; it did not replicate all twelve answers for this tool.
See all twelve answers and their evidence
| Question | Answer | Evidence / review | Source and reasoning |
|---|---|---|---|
| 1. Told it is AI | No | deployer-dependent Not independently replicated | Some state and federal laws require patient consent to use ambient scribing solutions.Source Nabla publishes a sample consent script titled "Patient consent example." Each clinic decides whether to use it. No Nabla document says the patient is always told. |
| 2. Operator and model maker named | No | not-documented Not independently replicated | internal artificial intelligence modelSource Nabla is named. The terms say Nabla trains its own "internal" model, but they do not say what model produces the notes. The Trust Center lists Google Cloud (hosting) and Azure (speech-to-text) as subprocessors and no language-model vendor. The Nabla AI Model Card is available only on request, so I could not read it. |
| 3. Patient chooses to use it | No | documented Not independently replicated | designed and intended to be used by healthcare professionals and other authorized usersSource The service is contracted by and for clinicians. The patient does not start it. The consent script has the clinician tell the patient they are using the tool. |
| 4. Patient sets the task | No | documented Not independently replicated | This tool will listen to our conversation and convert it into a summarySource The purpose (a clinical note) is fixed by the clinician and operator. |
| 5. Patient can decline or stop | No | deployer-dependent Not independently replicated | Do you consent to the use of this tool during our visit and future visits?Source This is an example script a clinic may or may not adopt. Nabla's documents do not state that a patient who declines still gets the same care. |
| 6. Patient sees the AI output | No | not-documented Not independently replicated | convert it into a summary, which I will review and edit for accuracySource The clinician reviews and edits the summary. The consent script says the audio is not saved. No source says the patient sees the AI's draft or transcript. |
| 7. Patient can correct or challenge | No | not-documented Not independently replicated | Quotation not recorded; evidence repair pending. Source No patient route to correct or contest the AI output is documented. Review is by the clinician only. |
| 8. Patient can get a copy | No | not-documented Not independently replicated | Quotation not recorded; evidence repair pending. Source The privacy policy lists access and portability rights. It defines its scope as website visitors, authorized users and email recipients, which does not clearly include patients. The Trust Center says audio is not stored by default. |
| 9. Patient can delete | No | not-documented Not independently replicated | We retain clinical notes for a short period of time (14 days), which is configurable by clientSource Retention is automatic and set by the client. The patient has no documented way to trigger deletion. The privacy policy's erasure right has the same scope ambiguity as Q8. |
| 10. Training or sale does not override patient choice | No | documented Not independently replicated | Nabla may collect, process, and otherwise use de-identified data that is transmitted to Nabla through your use of the Services for trainingSource Conflict: the binding terms let Nabla train on de-identified data from service use, with no patient opt-out. The terms add that "audio data does not include patient audio." The privacy policy also allows sharing de-identified health information with third parties. A separate Nabla page (https://nabla.com/copilot-audio-patient-consent) says patient consent is required to share audio, note and transcript to improve the service. That page is a sample script, and the terms take precedence per the rules. |
| 11. Patient can run it or take it elsewhere | No | not-documented Not independently replicated | No portion of the Services may be reproduced in any form or by any means.Source Clinician-facing SaaS under a user license. No self-hosting or patient portability path in the terms, privacy policy or trust page. |
| 12. No advertising or data business | No | documented Not independently replicated | Nabla may disclose such de-identified data in connection with the Services.Source The same clause says Nabla may collect and use de-identified data for training its internal AI model. The attached BAA lets Nabla de-identify PHI for product improvement. The clause states that audio data does not include patient audio. |
Initial coding: Claude Sonnet helpers, compiled by Claude Opus 5.5 (Anthropic). Selective review and corrections: GPT-6 Astra (OpenAI). Editor: Hugo Campos. Acceptance of corrections is not product verification.
Checklist rules · Independent review and limitations · Later evidence follow-up
Earlier v1.3 assessment and control finding
Historical assessment under different rules. It does not set the current checklist zone.
Agency finding, before method v1.3
Mixed
Control axis not applicable: clinician-operated
Historical editorial placement, pre-method: 40. No longer shown on the control axis.
This profile has not yet been reviewed under the published method. Its finding and any number are editorial placements made before the method existed.
- Evidence
- Documentary review. Public sources only, no hands-on testing by HugoScore.
- Review status
- AI draft. No person has settled the findings.
Earlier evidence and assessment
The sections below preserve the earlier review. Its classifications and provenance are historical; the checklist above gives the current draft classification.
Earlier finding · Control axis not applicable: clinician-operated
Method v1.3. The control line is evidence for how the agency finding arose, not a quality score. Legacy editorial placement, pre-method: 40. Not comparable with v1.3 positions.
Mixed
Nabla gives clinicians and healthcare organizations control over documentation, coding, and retention settings. Patient access, refusal, and correction depend on the deployment. Earlier consent and training assurances were not fully reverified in this pass.
Patient agency
How this tool changes agency
Reviewed documentation may improve later understanding, but no direct patient mechanism to inspect or contest generated notes was established. Coding traceability for clinicians is not automatically patient-accessible.
Current consent guidance, no-training promise scope, local refusal alternatives, transcript access, and patient correction mechanisms.
Patient agency assessment
Who sets and changes the goal?
Clinicians and organizations choose the workflow and retention settings. A patient may benefit without controlling the note's purpose, final content, or coding. The evidence supports this allocation, not a judgment from vendor ownership.
What can the patient understand, question, or do?
Reviewed documentation may improve later understanding, but no direct patient mechanism to inspect or contest generated notes was established. Coding traceability for clinicians is not automatically patient-accessible.
Can the patient evaluate the conditions of use?
Concrete retention and hosting disclosures are useful. The baseline's no-training-on-notes and consent claims were not fully reverified and should remain dated claims rather than universal guarantees.
Text findings
Conditions of use
Published controls and their limits
Concrete retention and hosting disclosures are useful. The baseline's no-training-on-notes and consent claims were not fully reverified and should remain dated claims rather than universal guarantees.
What remains unknown?
Not tested or not established
Current consent guidance, no-training promise scope, local refusal alternatives, transcript access, and patient correction mechanisms.
Who evaluated this?
AI-assisted public-source draft
Vendor statements describe published conditions, not independently verified behavior. No clinical, security, accessibility, or legal validation is claimed. Earlier evidence remains dated in the report and history.
Sources checked
Source-specific findings and retrieval limitations are recorded in the full report.
Earlier review provenance
Criteria
CAIHL-derived HugoScore framework and September 7 qualitative review priorities. Draft v1.2 numerical anchors remain unadopted.
Reviewer
AI-assisted public-source reassessment prepared in OpenAI Codex.
AI / model
OpenAI Codex / GPT-6
Human review
Hugo Campos authorized publication of these AI-assisted draft reassessments on September 8, 2026. This does not claim comprehensive human verification of every finding.
Review date
2026-09-08
Limitations
Current consent guidance, no-training promise scope, local refusal alternatives, transcript access, and patient correction mechanisms. No live product use, patient-data upload, account creation, code audit, clinical evaluation, or independent implementation validation.
Earlier review method
Focused public-source reassessment using CAIHL: patient authority, critical capacity, and informed control. Existing evidence plus one focused primary-source pass and at most one targeted follow-up. No live product testing. Numerical scores remain provisional editorial placements, not a new calculation.
Document-based draft · Medium for institutional deployment and retention statements, low for patient-facing rights (AI-assisted draft)